Asthma Inhaler Device Market Research Report - Forecast till 2027

Asthma Inhaler Device Market: Information by Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices), End User (Hospitals & Clinics, Homecare) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/1122-CR | February 2021 | Region: Global | 124 Pages         

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 16

2.2 RESEARCH OBJECTIVE 16

2.3 LIST OF ASSUMPTIONS 16

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

4.1 OVERVIEW 26

4.2 DRIVERS 27

4.2.1 RISING PREVALENCE OF ASTHMA 27

4.2.2 GROWING NEED FOR RESCUE MEDICATION 27

4.2.3 RISING DEMAND FOR METERED DOSE INHALERS 27

4.3 RESTRAINTS 29

4.3.1 TECHNICAL PROBLEMS WITH INHALER DEVICES 29

4.3.2 SIDE EFFECTS AND COMPLICATIONS DURING INHALATION 29

4.4 OPPORTUNITIES 30

4.4.1 ADVANCEMENT IN INHALER DEVICES 30

4.4.2 INCREASING DEMAND IN DEVELOPING COUNTRIES 30

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 31

5.1.1 BARGAINING POWER OF SUPPLIERS 32

5.1.2 BARGAINING POWER OF BUYERS 32

5.1.3 THREAT OF NEW ENTRANTS 32

5.1.4 THREAT OF SUBSTITUTES 32

5.1.5 INTENSITY OF RIVALRY 32

5.2 VALUE CHAIN ANALYSIS 33

5.2.1 R&D AND DESIGNING 34

5.2.2 MANUFACTURING 34

5.2.3 DISTRIBUTION 34

5.2.4 MARKETING AND SALES 34

5.2.5 POST-SALES MONITORING 34

6 ASTHMA INHALER DEVICE MARKET, BY TYPE

6.1 OVERVIEW 35

6.2 METERED DOSE INHALERS 37

6.3 DRY POWDER INHALERS 38

6.4 SOFT MIST INHALERS 39

7 ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

7.1 OVERVIEW 40

7.2 MANUALLY OPERATED INHALER DEVICES 41

7.3 DIGITALLY OPERATED INHALER DEVICES 42

8 ASTHMA INHALER DEVICE MARKET, BY END USER

8.1 OVERVIEW 43

8.2 HOSPITALS AND CLINICS 44

8.3 HOMECARE 45

8.4 OTHERS 45

9 GLOBAL ASTHMA INHALER DEVICE MARKET, BY REGION

9.1 OVERVIEW 46

9.2 AMERICAS 47

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.2.1 NORTH AMERICA 50

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.2.1.1 US 52

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.2.1.2 CANADA 53

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.2.2 LATIN AMERICA 54

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.3 EUROPE 56

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.3.1 WESTERN EUROPE 58

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.3.1.1 UK 60

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.3.1.2 GERMANY 61

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.3.1.3 FRANCE 63

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.3.1.4 ITALY 64

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.3.1.5 SPAIN 65

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.3.1.6 REST OF WESTERN EUROPE 67

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.3.2 EASTERN EUROPE 68

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.4 ASIA-PACIFIC 70

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.4.1.1 JAPAN 72

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.4.1.2 CHINA 73

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.4.1.3 INDIA 75

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.4.1.4 AUSTRALIA 76

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.4.1.5 SOUTH KOREA 77

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.4.1.6 REST OF ASIA-PACIFIC 79

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.5 MIDDLE EAST & AFRICA 81

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.5.1 MIDDLE EAST 83

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

9.5.2 AFRICA 85

ASTHMA INHALER DEVICE MARKET, BY TYPE

ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION

ASTHMA INHALER DEVICE MARKET, BY END USER

10 COMPETITIVE LANDSCAPE: GLOBAL ASTHMA INHALER DEVICE MARKET

10.1 OVERVIEW 87

10.2 COMPETITIVE ANALYSIS 87

10.3 COMPETITOR DASHBOARD 88

10.4 COMPETITIVE BENCHMARKING 89

10.5 MAJOR GROWTH STRATEGY IN THE GLOBAL ASTHMA INHALER DEVICE MARKET 90

10.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 90

10.7 KEY DEVELOPMENTS AND GROWTH STRATEGIES 91

10.7.1 COLLABORATION 91

10.7.2 ACQUISITION 92

10.7.3 PRODUCT APPROVAL AND LAUNCH 92

10.7.4 EXPANSION 93

10.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 93

10.8.1 SALES & OPERATING INCOME 93

10.8.2 R&D EXPENDITURE 94

11 COMPANY PROFILE

11.1 GLAXOSMITHKLINE PLC 95

11.1.1 COMPANY OVERVIEW 95

11.1.2 FINANCIAL OVERVIEW 95

11.1.3 PRODUCTS/SERVICES OFFERED 96

11.1.4 KEY DEVELOPMENTS 96

11.1.5 SWOT ANALYSIS 97

11.1.6 KEY STRATEGIES 97

11.2 KONINKLIJKE PHILIPS NV 98

11.2.1 COMPANY OVERVIEW 98

11.2.2 FINANCIAL OVERVIEW 98

11.2.3 PRODUCTS/SERVICES OFFERED 99

11.2.4 KEY DEVELOPMENTS 99

11.2.5 SWOT ANALYSIS 99

11.2.6 KEY STRATEGIES 100

11.3 ASTRAZENECA 101

11.3.1 COMPANY OVERVIEW 101

11.3.2 FINANCIAL OVERVIEW 101

11.3.3 PRODUCTS/SERVICES OFFERED 102

11.3.4 KEY DEVELOPMENTS 102

11.3.5 SWOT ANALYSIS 103

11.3.6 KEY STRATEGIES 103

11.4 CIPLA INC. 104

11.4.1 COMPANY OVERVIEW 104

11.4.2 FINANCIAL OVERVIEW 104

11.4.3 PRODUCTS/SERVICES OFFERED 105

11.4.4 KEY DEVELOPMENTS 105

11.4.5 SWOT ANALYSIS 105

11.4.6 KEY STRATEGIES 106

11.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 107

11.5.1 COMPANY OVERVIEW 107

11.5.2 FINANCIAL OVERVIEW 107

11.5.3 PRODUCTS/SERVICES OFFERED 108

11.5.4 KEY DEVELOPMENTS 108

11.5.5 SWOT ANALYSIS 109

11.5.6 KEY STRATEGIES 109

11.6 BEXIMCO PHARMACEUTICALS LTD 110

11.6.1 COMPANY OVERVIEW 110

11.6.2 FINANCIAL OVERVIEW 110

11.6.3 PRODUCTS/SERVICES OFFERED 111

11.6.4 KEY DEVELOPMENTS 111

11.6.5 SWOT ANALYSIS 111

11.6.6 KEY STRATEGIES 112

11.7 MERCK & CO., INC. 113

11.7.1 COMPANY OVERVIEW 113

11.7.2 FINANCIAL OVERVIEW 113

11.7.3 PRODUCTS/SERVICES OFFERED 114

11.7.4 KEY DEVELOPMENTS 114

11.7.5 SWOT ANALYSIS 114

11.7.6 KEY STRATEGIES 114

11.8 TEVA PHARMACEUTICAL INDUSTRIES LTD 115

11.8.1 COMPANY OVERVIEW 115

11.8.2 FINANCIAL OVERVIEW 115

11.8.3 PRODUCTS/SERVICES OFFERED 116

11.8.4 KEY DEVELOPMENTS 116

11.8.5 SWOT ANALYSIS 117

11.8.6 KEY STRATEGIES 117

11.9 CHIESI FARMACEUTICI SPA 118

11.9.1 COMPANY OVERVIEW 118

11.9.2 FINANCIAL OVERVIEW 118

11.9.3 PRODUCTS/SERVICES OFFERED 119

11.9.4 KEY DEVELOPMENTS 119

11.9.5 SWOT ANALYSIS 119

11.9.6 KEY STRATEGIES 120

11.10 MEDISOL LIFESCIENCE PVT. LTD 121

11.10.1 COMPANY OVERVIEW 121

11.10.2 FINANCIAL OVERVIEW 121

11.10.3 PRODUCTS/SERVICES OFFERED 121

11.10.4 KEY DEVELOPMENTS 121

11.10.5 SWOT ANALYSIS 122

11.10.6 KEY STRATEGIES 122

12 APPENDIX

12.1 REFERENCES 123

12.2 RELATED REPORTS 123

13 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 GLOBAL ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 36

TABLE 3 GLOBAL ASTHMA INHALER DEVICE MARKET FOR METERED DOSE INHALERS, BY REGION, 2020-2027 (USD MILLION) 37

TABLE 4 GLOBAL ASTHMA INHALER DEVICE MARKET FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 38

TABLE 5 GLOBAL ASTHMA INHALER DEVICE MARKET FOR DRY POWDER INHALERS, BY REGION, 2020-2027 (USD MILLION) 38

TABLE 6 GLOBAL ASTHMA INHALER DEVICE MARKET FOR SOFT MIST INHALERS, BY REGION, 2020-2027 (USD MILLION) 39

TABLE 7 GLOBAL ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 41

TABLE 8 GLOBAL ASTHMA INHALER DEVICE MARKET FOR MANUALLY OPERATED INHALER DEVICES, BY REGION,

2020-2027 (USD MILLION) 41

TABLE 9 GLOBAL ASTHMA INHALER DEVICE MARKET FOR DIGITALLY OPERATED INHALER DEVICES, BY REGION,

2020-2027 (USD MILLION) 42

TABLE 10 GLOBAL ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 44

TABLE 11 GLOBAL ASTHMA INHALER DEVICE MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2027 (USD MILLION) 44

TABLE 12 GLOBAL ASTHMA INHALER DEVICE MARKET FOR HOMECARE, BY REGION, 2020-2027 (USD MILLION) 45

TABLE 13 GLOBAL ASTHMA INHALER DEVICE MARKET, BY REGION, 2020-2027 (USD MILLION) 47

TABLE 14 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020-2027 (USD MILLION) 48

TABLE 15 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 48

TABLE 16 AMERICAS: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 48

TABLE 17 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 49

TABLE 18 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 49

TABLE 19 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 50

TABLE 20 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 50

TABLE 21 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 51

TABLE 22 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 51

TABLE 23 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 51

TABLE 24 US: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 52

TABLE 25 US: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 52

TABLE 26 US: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 52

TABLE 27 US: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 53

TABLE 28 CANADA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 53

TABLE 29 CANADA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 53

TABLE 30 CANADA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 54

TABLE 31 CANADA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 54

TABLE 32 LATIN AMERICA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 54

TABLE 33 LATIN AMERICA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 55

TABLE 34 LATIN AMERICA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 55

TABLE 35 LATIN AMERICA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 55

TABLE 36 EUROPE: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020-2027 (USD MILLION) 56

TABLE 37 EUROPE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 57

TABLE 38 EUROPE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 57

TABLE 39 EUROPE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 57

TABLE 40 EUROPE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 58

TABLE 41 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 58

TABLE 42 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 43 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 44 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 59

TABLE 45 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 60

TABLE 46 UK: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 60

TABLE 47 UK: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 60

TABLE 48 UK: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 61

TABLE 49 UK: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 61

TABLE 50 GERMANY: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 61

TABLE 51 GERMANY: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 52 GERMANY: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 62

TABLE 53 GERMANY: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 62

TABLE 54 FRANCE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 63

TABLE 55 FRANCE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 63

TABLE 56 FRANCE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 63

TABLE 57 FRANCE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 64

TABLE 58 ITALY: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 64

TABLE 59 ITALY: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 64

TABLE 60 ITALY: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 65

TABLE 61 ITALY: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 65

TABLE 62 SPAIN: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 63 SPAIN: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 64 SPAIN: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 66

TABLE 65 SPAIN: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 66

TABLE 66 REST OF WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 67

TABLE 67 REST OF WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE,

2020-2027 (USD MILLION) 67

TABLE 68 REST OF WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 67

TABLE 69 REST OF WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 68

TABLE 70 EASTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 71 EASTERN EUROPE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 72 EASTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 69

TABLE 73 EASTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 69

TABLE 74 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 70

TABLE 75 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 71

TABLE 76 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 71

TABLE 77 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 71

TABLE 78 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 72

TABLE 79 JAPAN: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 72

TABLE 80 JAPAN: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 72

TABLE 81 JAPAN: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 73

TABLE 82 JAPAN: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 73

TABLE 83 CHINA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 73

TABLE 84 CHINA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 74

TABLE 85 CHINA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 74

TABLE 86 CHINA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 74

TABLE 87 INDIA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 75

TABLE 88 INDIA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 75

TABLE 89 INDIA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 75

TABLE 90 INDIA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 76

TABLE 91 AUSTRALIA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 76

TABLE 92 AUSTRALIA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 76

TABLE 93 AUSTRALIA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 77

TABLE 94 AUSTRALIA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 77

TABLE 95 SOUTH KOREA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 77

TABLE 96 SOUTH KOREA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 78

TABLE 97 SOUTH KOREA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 78

TABLE 98 SOUTH KOREA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 78

TABLE 99 REST OF ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 79

TABLE 100 REST OF ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 79

TABLE 101 REST OF ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 79

TABLE 102 REST OF ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 80

TABLE 103 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020-2027 (USD MILLION) 81

TABLE 104 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 82

TABLE 105 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE,

2020-2027 (USD MILLION) 82

TABLE 106 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 82

TABLE 107 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 83

TABLE 108 MIDDLE EAST: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 83

TABLE 109 MIDDLE EAST: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 83

TABLE 110 MIDDLE EAST: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 84

TABLE 111 MIDDLE EAST: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 84

TABLE 112 AFRICA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 85

TABLE 113 AFRICA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 85

TABLE 114 AFRICA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 85

TABLE 115 AFRICA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 86

TABLE 116 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE ASTHMA INHALER DEVICE MARKET 90

TABLE 117 COLLABORATION: GLOBAL ASTHMA INHALER DEVICE MARKET 91

TABLE 118 ACQUISITION: GLOBAL ASTHMA INHALER DEVICE MARKET 92

TABLE 119 PRODUCT APPROVAL AND LAUNCH: GLOBAL ASTHMA INHALER DEVICE MARKET 92

TABLE 120 EXPANSION: GLOBAL ASTHMA INHALER DEVICE MARKET 93

TABLE 121 MAJOR PLAYERS R&D EXPENDITURE, 2020 94

TABLE 122 GLAXOSMITHKLINE PLC: PRODUCTS/SERVICES OFFERED 96

TABLE 123 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS 96

TABLE 124 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED 99

TABLE 125 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS 99

TABLE 126 ASTRAZENECA: PRODUCTS/SERVICES OFFERED 102

TABLE 127 ASTRAZENECA: KEY DEVELOPMENTS 102

TABLE 128 CIPLA INC.: PRODUCTS/SERVICES OFFERED 105

TABLE 129 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS/SERVICES OFFERED 108

TABLE 130 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS 108

TABLE 131 BEXIMCO PHARMACEUTICALS LTD: PRODUCTS/SERVICES OFFERED 111

TABLE 132 MERCK & CO., INC.: PRODUCTS/SERVICES OFFERED 114

TABLE 133 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT 115

TABLE 134 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED 116

TABLE 135 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS 116

TABLE 136 CHIESI FARMACEUTICI SPA: PRODUCTS/SERVICES OFFERED 119

TABLE 137 CHIESI FARMACEUTICI SPA: KEY DEVELOPMENTS 119

TABLE 138 MEDISOL LIFESCIENCE PVT. LTD: PRODUCTS/SERVICES OFFERED 121

14 LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 15

FIGURE 2 GLOBAL ASTHMA INHALER DEVICE MARKET: STRUCTURE 17

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 23

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF GLOBAL ASTHMA INHALER DEVICE MARKET 26

FIGURE 5 DRIVER IMPACT ANALYSIS 28

FIGURE 6 RESTRAINT IMPACT ANALYSIS 29

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ASTHMA INHALER DEVICE MARKET 31

FIGURE 8 VALUE CHAIN ANALYSIS OF THE GLOBAL ASTHMA INHALER DEVICE MARKET 33

FIGURE 9 GLOBAL ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020 (%) 35

FIGURE 10 GLOBAL ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 36

FIGURE 11 GLOBAL ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020 (%) 40

FIGURE 12 GLOBAL ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020 & 2027 (USD MILLION) 40

FIGURE 13 GLOBAL ASTHMA INHALER DEVICE MARKET, BY END USER, 2020 (%) 43

FIGURE 14 GLOBAL ASTHMA INHALER DEVICE MARKET, BY END USER, 2020 & 2027 (USD MILLION) 43

FIGURE 15 GLOBAL ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 (%) 46

FIGURE 16 GLOBAL ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 46

FIGURE 17 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 (%) 47

FIGURE 18 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET SHARE, BY COUNTRY, 2020 (%) 50

FIGURE 19 EUROPE: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 (%) 56

FIGURE 20 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET SHARE, BY COUNTRY, 2020 (%) 58

FIGURE 21 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET SHARE, BY COUNTRY, 2020 (%) 70

FIGURE 22 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 (%) 81

FIGURE 23 COMPETITOR DASHBOARD: GLOBAL ASTHMA INHALER DEVICE MARKET 88

FIGURE 24 BENCHMARKING OF MAJOR COMPETITORS 89

FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ASTHMA INHALER DEVICE MARKET 90

FIGURE 27 ASTHMA INHALER DEVICE MARKET, COMPETITIVE LANDSCAPE (% SHARE) 91

FIGURE 28 SALES & OPERATING INCOME, 2020 93

FIGURE 29 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW 95

FIGURE 30 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 97

FIGURE 31 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT 98

FIGURE 32 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 99

FIGURE 33 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT 101

FIGURE 34 ASTRAZENECA: SWOT ANALYSIS 103

FIGURE 35 CIPLA INC: FINANCIAL OVERVIEW SNAPSHOT 104

FIGURE 36 CIPLA INC.: SWOT ANALYSIS 105

FIGURE 37 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT 107

FIGURE 38 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SWOT ANALYSIS 109

FIGURE 39 BEXIMCO PHARMACEUTICALS LTD: FINANCIAL OVERVIEW SNAPSHOT 110

FIGURE 40 BEXIMCO PHARMACEUTICALS LTD: SWOT ANALYSIS 111

FIGURE 41 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT 113

FIGURE 42 MERCK & CO., INC.: SWOT ANALYSIS 114

FIGURE 43 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS 117

FIGURE 44 CHIESI FARMACEUTICI SPA: FINANCIAL OVERVIEW 118

FIGURE 45 CHIESI FARMACEUTICI SPA: SWOT ANALYSIS 119

FIGURE 46 MEDISOL LIFESCIENCE PVT. LTD: SWOT ANALYSIS 122

Asthma Inhaler Device Market

The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19.677.54 million by the end of 2020-2030.

Segmentation

By Type Metered Dose Inhalers Standard Pressurized Metered Dose Inhalers Breath Actuated Pressurized Metered Dose Inhalers Metered Dose Inhaler With A Spacer Dry Powder Inhalers Soft Mist Inhalers
By Mode of Operation Manually Operated Inhaler Devices Digitally Operated Inhaler Devices
By End-User Hospitals And Clinics Homecare Others

Key Players

  • GlaxoSmithKline plc (UK)
  • Koninklijke Philips NV (Netherlands)
  • AstraZeneca (UK)
  • Cipla Inc. (India)
  • Boehringer Ingelheim International GmbH (Germany)
  • Beximco Pharmaceuticals Ltd (Bangladesh)
  • Merck & Co. Inc. (the US)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Chiesi Farmaceutici SpA (Italy)
  • Medisol Lifescience Pvt. Ltd (India).

Drivers

  • High prevalence of asthma
  • Growing need for rescue medication
  • Rising demand for metered-dose inhalers
Speak to Analyst Request a Free Sample

Asthma Inhaler Device Market Overview


Based on the research, the Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19.677.54 million by the end of 2020-2030. 


Asthma, the chronic lung disease, is responsible for narrowing down and inflaming the airways. Problems like coughing, sneezing, tightness in the chest, difficulty breathing and shortness of breath are associated with asthma. asthma inhaler assistance devices are hand-held machines to treat such breathing problems. These machines are mainly used to treat or prevent diseases associated with the airways.


This report covers all the driving factor proving boost to the market growth. It also highlights many prominent key players of the market and what strategies they are adopting in order to sustain the high level of competition of the Asthma Inhaler Device Market. Post covid-19 scenario of the market and the market segmentations along with its regional analysis have been covered in the report.


Covid-19 impact


Although covid-19 has impacted most of the industries negatively, but it has also positive impact on some the few industries. Asthma Inhaler Device Market is one of such industries. A high amount of population was already suffering from asthma and covid-19 had made the situation even worse. As breathing problem is considered as one of the major symptoms of covid-19, it only increased the number of people suffering from breathing trouble.


Market dynamics


Drivers


Asthma Inhaler Device Market is expected to grow during the forecast period due to the rising cases of asthma. The prevalence of asthma in children and rising awareness among people are also increasing the demand for metered dose inhalers. This demands and rising awareness of asthma among people are driving the growth of the market.


Opportunities


Many prominent key players investing in research and development along with new product launches and collaborating with other players of the market are going to create a huge number of opportunities in the Asthma Inhaler Device Market.


Cumulative growth


In 2019, the retail pharmacies segment had the largest share of the Asthma Inhaler Device Market. North America had the largest market share of Asthma Inhaler in 2019.


Segmentation overview


Based on the global market, the Asthma Inhaler Device Market is segmented into-



  • Type

  • Mode of operation

  • End-User

  • Region


By Type


Based on type, the Asthma Inhaler Device Market is further segmented into-



  • Metered Dose Inhalers

  • Standard Pressurized Metered-Dose Inhalers

  • Breath-Actuated Pressurized Metered-Dose Inhalers

  • Metered-Dose Inhaler with a Spacer

  • Dry Powder Inhalers

  • Soft Mist Inhalers


By Mode of operation


Based on mode of operation, the Asthma Inhaler Device Market is further segmented into-



  • Manually Operated Inhaler Devices

  • Digitally Operated Inhaler Devices


By End-User


Based on end-user, the Asthma Inhaler Device Market is further segmented into-



  • Hospitals and Clinics

  • Homecare

  • Others


By Region


Based on region, the Asthma Inhaler Device Market is further segmented into-



  • Americas


    • North America


      • US

      • Canada


    • Latin America




  • Europe


    • Western Europe


      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe


    • Eastern Europe




  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific




  • Middle East & Africa


    • Middle East

    • Africa



Regional analysis


The regional Asthma Inhaler Device Market is broadly divided into the Americas, Europe, Asia-Pacific and the MEA.


Among all these regional markets, America is expected to be the most dominating region due to the increasing cases of asthma in the region. The rising demand for metered-dose inhaler and smart inhalers along with the technological advancements are providing a boost to the American Asthma Inhaler Device Market. Europe is expected to be the second largest region of the Asthma Inhaler Device Market during the forecast period. European Academy of Allergy & Clinical Immunology is making constant efforts to make people aware of the problem. The rising awareness among people and hospitals and patients adopting respiratory inhalers are driving the growth of the European market. In Asia-Pacific regional market is growing due to the rising prevalence of asthma in countries like India, china and Japan. The MEA is also expecting a steady growth because of the rising cases of asthma and demand  for better treatment.


Competitive landscape


The global Asthma Inhaler Device Market is highly competitive with the presence of many prominent key players in the market. To sustain in the completion of the market, the key players are embracing various strategies such as collaboration with other players, partnership, product launch, merger and acquisition and investment in research and developments.


Major key players



  • GlaxoSmithKline plc (UK)

  • Koninklijke Philips NV (Netherlands)

  • AstraZeneca (UK)

  • Cipla Inc. (India)

  • Boehringer Ingelheim International GmbH (Germany)

  • Beximco Pharmaceuticals Ltd (Bangladesh)

  • Merck & Co., Inc. (the US)

  • Teva Pharmaceutical Industries Ltd (Israel)

  • Chiesi Farmaceutici SpA (Italy)

  • and Medisol Lifescience Pvt. Ltd (India).


Report Overview


The report comprises of



  • Market overview

  • Covid-19 impact

  • Market dynamics

  • Drivers

  • Challenges

  • Restrains

  • Opportunities

  • Technological analysis

  • Segmentation overview

  • Regional analysis

  • Competitive landscape

  • Recent developments

  • Major key players



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2025: USD 19,677.54 Million
  • 2030: Significant Value
  •   CAGR   6.42% (2020-2030)
      Base Year   2019
      Forecast Period   2020-2030
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Mode of Operation, End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   GlaxoSmithKline plc (UK), Koninklijke Philips NV (Netherlands), AstraZeneca (UK), Cipla Inc. (India), Boehringer Ingelheim International GmbH (Germany), Beximco Pharmaceuticals Ltd (Bangladesh), Merck & Co., Inc. (the US), Teva Pharmaceutical Industries Ltd (Israel), Chiesi Farmaceutici SpA (Italy), and Medisol Lifescience Pvt. Ltd (India).
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • High prevalence of asthma
  • Growing need for rescue medication
  • Rising demand for metered-dose inhalers


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Asthma Inhaler Device Market is predicted to touch USD 19, 677.54 million by 2025.

    Asthma Inhaler Device Market is projected to grow at a 6.42% CAGR between 2016-2025.

    Americas are projected to have a major share in the Asthma Inhaler Device Market.

    Key competitors in the Asthma Inhaler Device Market include Medisol Lifescience Pvt. Ltd (India), Chiesi Farmaceutici SpA (Italy), Teva Pharmaceutical Industries Ltd (Israel), Merck & Co., Inc. (the US), Beximco Pharmaceuticals Ltd (Bangladesh), Boehringer Ingelheim International GmbH (Germany), Cipla Inc. (India), AstraZeneca (UK), Koninklijke Philips NV (Netherlands), and GlaxoSmithKline plc (UK).

    Specific strategies adopted by key players to create a footprint in the Asthma Inhaler Device Market include acquisition, expansion, collaborations, product launch and approval.